Joe Kozlowski
Papers
1
Total Citations
6
H-Index
1
About
Joe Kozlowski is a leading researcher in HIV eradication and pharmacokinetic/pharmacodynamic (PK/PD) modeling, with a focus on latency reversal strategies. His work centers on developing novel approaches to eliminate the latent HIV reservoir—a major barrier to curing chronic infection. Kozlowski’s most cited study, “In Vitro Pharmacokinetic/Pharmacodynamic Modeling of HIV Latency Reversal by Novel HDAC Inhibitors Using an Automated Platform” (2021, 6 citations), introduces an innovative automated platform to evaluate histone deacetylase inhibitors (HDACis) for reactivating latent HIV. This contribution advances the understanding of how HDACis can be optimized for latency reversal, offering a scalable method to screen potential therapeutics. By integrating PK/PD modeling with high-throughput automation, Kozlowski’s work bridges preclinical drug development and clinical translation, providing a framework for designing more effective HIV cure strategies. His research is pivotal for researchers and students exploring targeted interventions against HIV persistence, highlighting the potential of precision pharmacology to overcome treatment limitations. Kozlowski’s efforts underscore his commitment to tackling one of HIV therapy’s most formidable challenges, with implications for reducing lifelong antiretroviral dependence.
Research Focus
Key Achievements
Top Papers
- 1